Multivariable analysis for PFS and OS
| Variable . | PFS . | OS . | ||
|---|---|---|---|---|
| HR (95% CI) . | P value . | HR (95% CI) . | P value . | |
| Race | .03 | .10 | ||
| Asian vs Caucasian | 1.59 (0.94-2.7) | .08 | 0.86 (0.47-1.56) | .61 |
| AA vs Caucasian | 1.72 (1.05-2.82) | .03 | 0.51 (0.28-0.95) | .03 |
| Insurance | < .001 | < .001 | ||
| Medicaid vs Medicare | 2.07 (1.18-3.61) | .01 | 3.23 (1.55-6.72) | .002 |
| Private vs Medicare | 1.33 (0.97-1.83) | .08 | 0.94 (0.64-1.38) | .76 |
| Self-pay vs Medicare | 7.69 (3.1-19.1) | < .001 | 3.51 (1.44-8.54) | .006 |
| Age | 1.01 (1.0-1.02) | .2 | 0.99 (0.98-1.01) | .43 |
| Prior autologous SCT | 0.79 (0.57-1.1) | .16 | 0.87 (0.59-1.29) | .49 |
| Use of any bridging | 1.59 (1.19-2.12) | .002 | 1.51 (1.06-2.15) | .02 |
| CAR-Ts received on trial | 1.08 (0.77-1.51) | .67 | 1.47 (1.01-2.14) | .04 |
| IPI (4-5) at time of collection | 1.18 (0.83-1.68) | .36 | 1.24 (0.84-1.84) | .29 |
| LDH elevated at time of collection | 1.69 (1.25-2.28) | .001 | 0.91 (0.65-1.27) | .57 |
| Further therapy after CAR-Ts received | - | - | 0.64 (0.46-0.9) | .01 |
| Variable . | PFS . | OS . | ||
|---|---|---|---|---|
| HR (95% CI) . | P value . | HR (95% CI) . | P value . | |
| Race | .03 | .10 | ||
| Asian vs Caucasian | 1.59 (0.94-2.7) | .08 | 0.86 (0.47-1.56) | .61 |
| AA vs Caucasian | 1.72 (1.05-2.82) | .03 | 0.51 (0.28-0.95) | .03 |
| Insurance | < .001 | < .001 | ||
| Medicaid vs Medicare | 2.07 (1.18-3.61) | .01 | 3.23 (1.55-6.72) | .002 |
| Private vs Medicare | 1.33 (0.97-1.83) | .08 | 0.94 (0.64-1.38) | .76 |
| Self-pay vs Medicare | 7.69 (3.1-19.1) | < .001 | 3.51 (1.44-8.54) | .006 |
| Age | 1.01 (1.0-1.02) | .2 | 0.99 (0.98-1.01) | .43 |
| Prior autologous SCT | 0.79 (0.57-1.1) | .16 | 0.87 (0.59-1.29) | .49 |
| Use of any bridging | 1.59 (1.19-2.12) | .002 | 1.51 (1.06-2.15) | .02 |
| CAR-Ts received on trial | 1.08 (0.77-1.51) | .67 | 1.47 (1.01-2.14) | .04 |
| IPI (4-5) at time of collection | 1.18 (0.83-1.68) | .36 | 1.24 (0.84-1.84) | .29 |
| LDH elevated at time of collection | 1.69 (1.25-2.28) | .001 | 0.91 (0.65-1.27) | .57 |
| Further therapy after CAR-Ts received | - | - | 0.64 (0.46-0.9) | .01 |
CI, confidence interval; IPI, International Prognostic Index.